Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
BioLife Solutions, Inc. BLFS
$18.86
+$0.63 (3.34%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
776416730.00000000
-
week52high
26.96
-
week52low
10.40
-
Revenue
161759000
-
P/E TTM
-6
-
Beta
1.84186800
-
EPS
-3.38000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 20:00
Описание компании
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Stephens & Co. | Overweight | Overweight | 10 мая 2022 г. |
| Keybanc | Overweight | Overweight | 10 мая 2022 г. |
| Oppenheimer | Outperform | Perform | 25 апр 2022 г. |
| Keybanc | Overweight | Overweight | 13 авг 2021 г. |
| Benchmark | Hold | Buy | 14 мая 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Mathew Aby J. | D | 150000 | 10000 | 02 февр 2023 г. |
| Mathew Aby J. | D | 273765 | 9000 | 02 февр 2023 г. |
| Mathew Aby J. | A | 282765 | 9000 | 02 февр 2023 г. |
| Mathew Aby J. | A | 274765 | 1000 | 02 февр 2023 г. |
| Mathew Aby J. | D | 160000 | 10000 | 01 февр 2023 г. |
| Mathew Aby J. | D | 273765 | 10000 | 01 февр 2023 г. |
| Mathew Aby J. | A | 283765 | 10000 | 01 февр 2023 г. |
| Berard Todd | D | 40000 | 3500 | 23 янв 2023 г. |
| Berard Todd | D | 119265 | 3500 | 23 янв 2023 г. |
| Berard Todd | A | 122765 | 3500 | 23 янв 2023 г. |
Новостная лента
BioLife Solutions, Inc. (BLFS) Q1 2023 Earnings Call Transcript
Seeking Alpha
10 мая 2023 г. в 21:30
BioLife Solutions, Inc. (NASDAQ:BLFS ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Troy Wichterman - CFO Michael Rice - Chairman & CEO Conference Call Participants Jacob Johnson - Stephens Inc. Thomas Flaten - Lake Street Capital Markets Chad Wiatrowski - TD Cowen Carl Byrnes - Northland Capital Markets Yuan Zhi - B. Riley Securities Paul Knight - KeyBanc Capital Markets Operator Hello.
BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research
10 мая 2023 г. в 18:59
BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.17 per share a year ago.
BioLife Solutions: Capitalizing On The Future Of Biopreservation
Seeking Alpha
28 мар 2023 г. в 12:08
BioLife Solutions, a leading provider of bioproduction tools and services, is poised for growth as the demand for biologics and regenerative medicine increases. CryoStor and HypoThermosol have shown significant improvement to the post-preservation viability of biologic materials during manufacturing, storage, and distribution.
BioLife Solutions Is Set To Finally Absorb Its Acquisitions
Seeking Alpha
25 мар 2023 г. в 07:51
An acquisition spree has produced a host of problems, costs, write-offs, a collapse in gross margins and profits, cash bleed, and significant dilution. While only the evo and Sexton acquisitions have been a real success, the problems at some of the others now seem to be largely in the rearview mirror.
BioLife Solutions, Inc. (BLFS) Q4 2022 Earnings Call Transcript
Seeking Alpha
16 мар 2023 г. в 21:55
BioLife Solutions, Inc. (NASDAQ:BLFS ) Q4 2022 Earnings Conference Call March 16, 2023 4:30 PM ET Company Participants Troy Wichterman – Chief Financial Officer Mike Rice – Chairman and Chief Executive Officer Conference Call Participants Jacob Johnson – Stephens Yuan Zhi – B. Riley Thomas Flaten – Lake Street Operator Good day, and welcome to the BioLife Solutions' Fourth Quarter 2022 and Full Year Earnings Call.